118 related articles for article (PubMed ID: 25346122)
21. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
[TBL] [Abstract][Full Text] [Related]
22. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
23. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases.
Gwin K; Wheeler DT; Bossuyt V; Tavassoli FA
Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
25. Correlation of clinicopathologic parameters and immunohistochemical features of triple-negative invasive lobular carcinoma.
Harbhajanka A; Lamzabi I; Singh RI; Ghai R; Reddy VB; Bitterman P; Gattuso P
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):e18-26. PubMed ID: 25003839
[TBL] [Abstract][Full Text] [Related]
26. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.
Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z
Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553
[TBL] [Abstract][Full Text] [Related]
27. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
Reyes C; Jorda M; Gomez-Fernández C
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
[TBL] [Abstract][Full Text] [Related]
28. Spindle cell metaplastic carcinoma of breast: A clinicopathological and immunohistochemical analysis.
Zhu H; Li K; Dong DD; Fu J; Liu DD; Wang L; Xu G; Song LH
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e72-e78. PubMed ID: 25483573
[TBL] [Abstract][Full Text] [Related]
29. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
[TBL] [Abstract][Full Text] [Related]
30. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
Carter MR; Hornick JL; Lester S; Fletcher CD
Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
[TBL] [Abstract][Full Text] [Related]
31. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up.
D'Alfonso TM; Ginter PS; Liu YF; Shin SJ
Am J Surg Pathol; 2014 Jan; 38(1):45-53. PubMed ID: 24121179
[TBL] [Abstract][Full Text] [Related]
32. Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07).
Yu JI; Choi DH; Huh SJ; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Kim JH; Cho J; Kim IA; Lee JH; Park W
Clin Breast Cancer; 2015 Apr; 15(2):e105-15. PubMed ID: 25459069
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.
Yamaguchi R; Tanaka M; Kondo K; Yokoyama T; Maeda I; Tsuchiya S; Yamaguchi M; Takahashi R; Ogata Y; Abe H; Akiba J; Nakashima O; Kage M; Yano H
Med Mol Morphol; 2012 Dec; 45(1):14-21. PubMed ID: 22431179
[TBL] [Abstract][Full Text] [Related]
34. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
Barnes PJ; Boutilier R; Chiasson D; Rayson D
Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast.
Ma X; Han Y; Fan Y; Cao X; Wang X
Breast J; 2014; 20(2):166-73. PubMed ID: 24400866
[TBL] [Abstract][Full Text] [Related]
36. Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile.
Takahashi S; Thike AA; Koh VCY; Sasano H; Tan PH
Virchows Arch; 2018 Sep; 473(3):275-283. PubMed ID: 30033510
[TBL] [Abstract][Full Text] [Related]
37. Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population.
Hashmi AA; Naz S; Hashmi SK; Hussain ZF; Irfan M; Bakar SMA; Faridi N; Khan A; Edhi MM
BMC Res Notes; 2018 Jun; 11(1):372. PubMed ID: 29884220
[TBL] [Abstract][Full Text] [Related]
38. Matrix-producing carcinoma: a rare variant of metaplastic breast carcinoma with heterologous elements.
Ayar S; Dyess DL; Carter E
Breast J; 2010; 16(4):420-3. PubMed ID: 20522099
[TBL] [Abstract][Full Text] [Related]
39. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic features of atypical spindle cell lipomatous tumor].
Zhao M; Wang YB; Yan YJ; Wang W; Ru GQ; He XL
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):99-104. PubMed ID: 29429160
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
